Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor

Laboratory Investigation

Volumn 76, Issue 2, 1997, Pages 245-255

  Brown, Lawrence F ^a   Detmar, Michael ^a   Tognazzi, Kathi ^a   Abu Jawdeh, Graziella ^a   Iruela Arispe, Maria Luisa ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; COLON MUCOSA; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADULT; AGED; BLOTTING, NORTHERN; CELL CULTURE TECHNIQUES; COLON; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; LYMPHOKINES; MIDDLE AGED; MUSCLE, SMOOTH; MYOMETRIUM; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031044803     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Berse B, Brown LF, Van De Water L, Dvorak HF, and Senger DR (1992). Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220.
2. Boocock C, Charnock-Jones D, Sharkey A, McLaren J, Barker P, Wright K, Twentyman P, and Smith S (1995). Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Nat Cancer Inst 87:506-516.
3. Brogi E, Wu T, Namiki A, and Isner JM (1994). Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90:649-652.
4. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, and Senger DR (1993a). Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255-1262.
5. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, and Dvorak HF (1993b). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727-4735.
6. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van De Water L, Senger D, Dvorak H, and Rosen S (1992a). Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42:1457-1461.
7. Brown LF, Harrist TJ, Yeo KT, Stahle-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, and Detmar M (1995a). Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 104:744-749.
8. Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Manseau EJ, Dvorak HF, and Van De Water L (1995b). Expression of vascular permeability factor in delayed hypersensitivity skin reactions. J Immunol 154:2801-2807.
9. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, and Van De Water L (1992b). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176: 1375-1379.
10. Charnock-Jones D, Sharkey A, Boocock C, Ahmed A, Plevin R, Ferrara N, and Smith S (1994). Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 51:524-530.
11. Cohen T, Gitay GH, Sharon R, Shibuya M, Halaban R, Levi BZ, and Neufeld G (1995). VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270:11322-11326.
12. Cullinan-Bove K and Koos R (1993). Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133:829-837.
13. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, and Dvorak HF (1994). Overexpression of vascular permeability factor and its receptors in psoriasis. J Exp Med 180:1141-1146.
14. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, and Williams LT (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
15. Dolecki GJ and Connolly DT (1991). Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. Biochem Biophys Res Commun 180:572-578.
16. Dvorak HF, Orenstein NS, Carvalho AC, Churchill WH, Dvorak AM, Galli SJ, Feder J, Bitzer AM., Rypysc J, and Giovinco P (1979). Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol 122:166-174.
17. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van De Water L, and Senger DR (1991). Distribution of vascular permeabilty factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 174:1275-1278.
18. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Berse B, Jackman RJ, Senger DR, Dvorak HF, and Brown LF (1994). Vascular permeability factor/endothelial growth factor (VPF/ VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341-346.
19. Ferrara N and Henzel WJ (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858.
20. Finkenzeller G, Marme D, Weich HA, and Hug H (1992). Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res 52:4821-4823.
21. ffrench-Constant C, Van De Water L, Dvorak HF, and Hynes RO (1989). Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903-914.
22. Gitay-Goren H, Halaban R, and Neufeld G (1993). Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem Biophys Res Commun 190:702-709.
23. Goldberg MA and Schneider TJ (1994). Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269:4355-4359.
24. Gospodarowicz D, Abraham JA, and Schilling J (1989). Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci U S A, 86:7311-7315.
25. Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, and Plouet J (1995). Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol, 164(2), 385-94.
26. Harrison-Woolrych ML, Sharkey AM, Charnock-Jones DS, and Smith SK (1995). Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata. J Clin Endocrinol Metab 80:1853-1858.
27. Iruela-Arispe ML and Sage EH (1993). Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-B1. J Cell Biochem 52:414-430.
28. Kamat BR, Brown LF, Manseau EJ, Senger DR, and Dvorak HF (1995). Expression of vascular permeability factor/ vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 146:157-165.
29. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, and Connolly DT (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312.
30. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, and Ferrara N (1994). Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149-4156.
31. Koos RD and Olson CE (1991). Hypoxia stimulates expression of the gene for vascular endothelial growth factor (VEGF), a putative angiogenic factor, by granulosa cells of the ovarian follicle, a site of angiogenesis (abstract). J Cell Biol 115:421a.
32. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680-685.
33. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
34. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, and Alitalo K (1994). Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269: 6271-6274.
35. Phillips HS, Hains J, Leung DW, and Ferrara N (1990). Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127:965-967.
36. Plate KH, Breier G, Weich HA, and Risau W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848.
37. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, and Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
38. Senger DR, Perruzzi CA, Feder J, and Dvorak HF (1986). A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5632.
39. Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L, Connolly D, Stern D, and Kao J (1993). Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81:2767-2773.
40. Shweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
41. Terman BI, Dougher Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, and Bohlen P (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187:1579-1586.
42. Wilson EA, Yang F, and Rees ED (1980). Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues. Obstet Gynecol 55:20-24.